Condition
Opioid Cessation
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07226700Phase 3Recruiting
Suzetrigine in Total Hip Arthroplasty
NCT03659734Not ApplicableCompletedPrimary
Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation
NCT02070003Not ApplicableCompletedPrimary
Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT)
Showing all 3 trials